TUESDAY, Dec. 19 (HealthDay News) -- U.S. authorities are proposing stricter warning labels for popular over-the-counter pain relievers such as aspirin and Tylenol.
The warnings, which would address the potential for stomach bleeding as well as liver damage, would apply to acetaminophen products such as Tylenol as well as nonsteroidal anti-inflammatory drugs (NSAIDs) such as aspirin and ibuprofen (Advil, Motrin), naproxen (Aleve) and ketoprofen (Oruvail).
Many product manufacturers already have voluntary warnings on their labels.
The new rule would make the warnings mandatory, would require the warnings to be more prominently displayed and would require standardized language, Dr. Charles Ganley, director of the U.S. Food and Drug Administration's Office of Nonprescription Products, Center for Drug Evaluation and Research, said during a Tuesday afternoon teleconference.
>Read the whole article here.
No comments:
Post a Comment